Total nodule number as an independent prognostic factor in resected stage III non-small cell lung cancer: a deep learning-powered study.

Nodule number artificial intelligence multiple pulmonary nodules non-small cell lung cancer (NSCLC) prognosis

Journal

Annals of translational medicine
ISSN: 2305-5839
Titre abrégé: Ann Transl Med
Pays: China
ID NLM: 101617978

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 22 06 2021
accepted: 02 11 2021
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 15 3 2022
Statut: ppublish

Résumé

Almost every patient with lung cancer has multiple pulmonary nodules; however, the significance of nodule multiplicity in locally advanced non-small cell lung cancer (NSCLC) remains unclear. We identified patients who had undergone surgical resection for stage I-III NSCLC at the Peking University People's Hospital from 2005 to 2018 for whom preoperative chest computed tomography (CT) scans were available. Deep learning-based artificial intelligence (AI) algorithms using convolutional neural networks (CNN) were applied to detect and classify pulmonary nodules (PNs). Maximally selected log-rank statistics were used to determine the optimal cutoff value of the total nodule number (TNN) for predicting survival. A total of 33,410 PNs were detected by AI among the 2,126 participants. The median TNN detected per person was 12 [interquartile range (IQR) 7-20]. It was revealed that AI-detected TNN (analyzed as a continuous variable) was an independent prognostic factor for both recurrence-free survival (RFS) [hazard ratio (HR) 1.012, 95% confidence interval (CI): 1.002 to 1.022, P=0.021] and overall survival (OS) (HR 1.013, 95% CI: 1.002 to 1.025, P=0.021) in multivariate analyses of the stage III cohort. In contrast, AI-detected TNN was not significantly associated with survival in the stage I and II cohorts. In a survival tree analysis, rather than using traditional IIIA and IIIB classifications, the model grouped cases according to AI-detected TNN (lower The AI-detected TNN is significantly associated with survival rates in patients with surgically resected stage III NSCLC. A lower TNN detected on preoperative CT scans indicates a better prognosis for patients who have undergone complete surgical resection.

Sections du résumé

Background UNASSIGNED
Almost every patient with lung cancer has multiple pulmonary nodules; however, the significance of nodule multiplicity in locally advanced non-small cell lung cancer (NSCLC) remains unclear.
Methods UNASSIGNED
We identified patients who had undergone surgical resection for stage I-III NSCLC at the Peking University People's Hospital from 2005 to 2018 for whom preoperative chest computed tomography (CT) scans were available. Deep learning-based artificial intelligence (AI) algorithms using convolutional neural networks (CNN) were applied to detect and classify pulmonary nodules (PNs). Maximally selected log-rank statistics were used to determine the optimal cutoff value of the total nodule number (TNN) for predicting survival.
Results UNASSIGNED
A total of 33,410 PNs were detected by AI among the 2,126 participants. The median TNN detected per person was 12 [interquartile range (IQR) 7-20]. It was revealed that AI-detected TNN (analyzed as a continuous variable) was an independent prognostic factor for both recurrence-free survival (RFS) [hazard ratio (HR) 1.012, 95% confidence interval (CI): 1.002 to 1.022, P=0.021] and overall survival (OS) (HR 1.013, 95% CI: 1.002 to 1.025, P=0.021) in multivariate analyses of the stage III cohort. In contrast, AI-detected TNN was not significantly associated with survival in the stage I and II cohorts. In a survival tree analysis, rather than using traditional IIIA and IIIB classifications, the model grouped cases according to AI-detected TNN (lower
Conclusions UNASSIGNED
The AI-detected TNN is significantly associated with survival rates in patients with surgically resected stage III NSCLC. A lower TNN detected on preoperative CT scans indicates a better prognosis for patients who have undergone complete surgical resection.

Identifiants

pubmed: 35282064
doi: 10.21037/atm-21-3231
pii: atm-10-02-33
pmc: PMC8848356
doi:

Types de publication

Journal Article

Langues

eng

Pagination

33

Informations de copyright

2022 Annals of Translational Medicine. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-21-3231/coif). XC reports funding from the National Natural Science Foundation of China (82002983). DW, JS, and WT were employed by the company Beijing Infervision Technology Co., Ltd. The other authors have no conflicts of interest to declare.

Références

N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Chest. 2013 May;143(5 Suppl):e78S-e92S
pubmed: 23649455
Br J Radiol. 2018 Oct;91(1090):20180028
pubmed: 29869919
Med Phys. 2003 Mar;30(3):461-72
pubmed: 12674248
Comput Math Methods Med. 2016;2016:6215085
pubmed: 28070212
Am J Surg Pathol. 2009 Dec;33(12):1752-64
pubmed: 19773638
Comput Methods Programs Biomed. 2018 Aug;162:109-118
pubmed: 29903476
Lung Cancer. 2018 Nov;125:103-108
pubmed: 30429006
Sci Rep. 2016 Apr 15;6:24454
pubmed: 27079888
Eur Radiol. 2018 Jan;28(1):226-234
pubmed: 28643093
Thorax. 2018 Mar;73(3):290-292
pubmed: 29056599
IEEE Trans Biomed Eng. 2017 Jul;64(7):1558-1567
pubmed: 28113302
J Thorac Oncol. 2016 May;11(5):666-680
pubmed: 26940527
Chest. 2013 May;143(5 Suppl):e93S-e120S
pubmed: 23649456
Lung Cancer. 2017 Nov;113:45-50
pubmed: 29110848
J Med Imaging (Bellingham). 2017 Oct;4(4):041308
pubmed: 29181428
Radiographics. 2017 Mar-Apr;37(2):505-515
pubmed: 28212054
Lancet Oncol. 2016 Jul;17(7):907-916
pubmed: 27283862
IEEE Trans Med Imaging. 2019 Apr;38(4):991-1004
pubmed: 30334786
Med Image Anal. 2017 Dec;42:1-13
pubmed: 28732268
Onco Targets Ther. 2015 Aug 04;8:2015-22
pubmed: 26346558
N Engl J Med. 2013 Sep 5;369(10):910-9
pubmed: 24004118
Radiol Artif Intell. 2019 May 29;1(3):e180084
pubmed: 33937792
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
Clin Radiol. 2020 Jan;75(1):13-19
pubmed: 31202567
Thorax. 2016 Apr;71(4):367-75
pubmed: 26921304
EBioMedicine. 2019 Jun;44:162-181
pubmed: 31129095
Diagn Interv Imaging. 2016 Oct;97(10):1003-1017
pubmed: 27567555
J Thorac Oncol. 2016 May;11(5):639-650
pubmed: 26940528
Thorax. 2015 Aug;70 Suppl 2:ii1-ii54
pubmed: 26082159
Radiology. 2017 Jul;284(1):228-243
pubmed: 28240562
IEEE Trans Med Imaging. 2016 May;35(5):1160-1169
pubmed: 26955024
Korean J Radiol. 2020 May;21(5):511-525
pubmed: 32323497
J Nucl Med. 2007 Jun;48(6):932-45
pubmed: 17504879
Lancet Oncol. 2014 Nov;15(12):1332-41
pubmed: 25282285
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1208-14
pubmed: 26214244
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
CA Cancer J Clin. 2017 Mar;67(2):100-121
pubmed: 28170086
J Natl Compr Canc Netw. 2018 Apr;16(4):412-441
pubmed: 29632061

Auteurs

Xiuyuan Chen (X)

Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.

Qingyi Qi (Q)

Department of Radiology, Peking University People's Hospital, Beijing, China.

Zewen Sun (Z)

Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.

Dawei Wang (D)

Institute of Advanced Research, Beijing Infervision Technology Co., Ltd., Beijing, China.

Jinlong Sun (J)

Institute of Advanced Research, Beijing Infervision Technology Co., Ltd., Beijing, China.

Weixiong Tan (W)

Institute of Advanced Research, Beijing Infervision Technology Co., Ltd., Beijing, China.

Xianping Liu (X)

Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.

Taorui Liu (T)

Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.

Nan Hong (N)

Department of Radiology, Peking University People's Hospital, Beijing, China.

Fan Yang (F)

Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.

Classifications MeSH